GERMANTOWN, Md.--(BUSINESS WIRE)--Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX), today announced the appointment of Philip Frost, M.D., Ph.D., to its Board of Directors effective March 14, 2008. The addition of Dr. Frost brings the Avalon Board to eight members.
